dactinomycin and Pancreatic Neoplasms

dactinomycin has been researched along with Pancreatic Neoplasms in 39 studies

Research

Studies (39)

TimeframeStudies, this research(%)All Research%
pre-199011 (28.21)18.7374
1990's12 (30.77)18.2507
2000's12 (30.77)29.6817
2010's4 (10.26)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Borrelli, MJ; Crooks, PA; Lamture, G1
Cheng, Y; Hao, L; Huang, S; Wei, W; Wu, Z1
Carralot, JP; Liu, XF; Niederfellner, G; Pastan, I; Prunotto, M; Xiang, L; Zhou, Q1
Bortolotti, C; Fürst, J; Geibel, JP; Hartl, A; Hufnagl, C; Jakab, M; Kunit, T; Langelueddecke, C; Moder, A; Ritter, M; Schmidt, S1
Erkan, M; Friess, H; Kleeff, J; Pan, Z; Streit, S1
Li, C; Olberding, KE; Pan, J; Rai, SN; Wang, X; Zhu, Y1
Alrefai, W; Anderson, KM; Bonomi, P; Dudeja, P; Harris, JE; Hu, Y; Seed, TM1
LANGDON, EA; OTTOMAN, RE; ROCHLIN, DB; SMART, CR1
FALKSON, G; SNYMAN, HJ1
TIMOFEEVSKAIA, EA1
BOLL, I; KRUECKEMEYER, K1
Hoffarth, S; Huber, C; Milosevic, J; Schuler, M1
Adrian, TE; Bell, RH; Bentrem, DJ; Ding, XZ; Fought, AJ; Golkar, L; Kelly, DL; Salabat, MR; Scholtens, D; Talamonti, MS; Ujiki, MB1
Baba, H; Ishiko, T; Kamohara, H; Ogawa, M; Takahashi, M1
Fukasawa, M; Korc, M; Matsushita, A1
Buchanan, KD; Cantwell, B; Collins, PG; Fennelly, JJ; Fielding, JF; FitzGerald, O1
Fujii, J; Kamada, T; Kaneto, H; Matsuoka, T; Nakamura, M; Seo, HG; Suzuki, K; Taniguchi, N; Tatsumi, H; Yamasaki, Y1
Egan, JM; Montrose-Rafizadeh, C; Nadiv, O; Raygada, M; Roth, J; Wang, Y1
Ausiello, DA; Breuer, W; Cabantchik, IZ; Glickstein, H; Kartner, N; Riordan, JR1
Kuramoto, M; Ogawa, M; Yamashita, J1
Buchanan, KD; Courtney, MG; Fielding, JF; Holloway, H; Lane, BE; Leavey, SF; Royston, D1
Dalgleish, AG; Gibson, FM; Gordon-Smith, EC; Marsh, JC; Philpott, NJ; Scopes, J; Turner, AJ; Westby, M1
Cheng, MY; Lee, AC; Wong, KW1
Beglinger, C; Eberle, AN; Froidevaux, S; Hintermann, E; Mäcke, HR; Török, M1
Farrelly, ER; Hirakawa, K; Ho, JJ; Kim, YS; Sowa, M; Yamashita, Y1
Kleeff, J; Korc, M; Kornmann, M; Sawhney, H1
Batra, SK; Matsuzaki, H; Picha, KS; Pour, PM; Schmied, BM; Schneider, MB; Standop, J; Ulrich, A1
Adsay, VN; Glazyrin, AL; Sarkar, FH; Vaitkevicius, VK1
Adsay, VN; Alhasan, S; Chinni, S; Glazyrin, AL; Sarkar, FH; Vaitkevicius, VK1
Arimura, GK; Wu, M; Yunis, AA1
Cubilla, AL; Hajdu, SI1
Barkin, J; Bateman, J; Brooks, J; Chaffe, J; Douglass, HO; Frytak, S; Hahn, RG; Kalser, M; Knowlton, A; Lavin, PT; Lessner, H; Like, A; Livstone, E; Lokich, J; Mann-Kaplan, R; Milliron, S; Moertel, CG; O'Connell, MJ; Ramming, K; Redlhammer, D; Reitemeier, RJ; Rubin, J; Schein, PS; Schutt, AJ; Silverman, M; Spiro, H; Troner, M; Weiland, LH; Zamcheck, N1
Chuang, LM; Jou, TS; Lin, BJ; Tai, TY; Wu, HP1
Bachy, B; Caillaud, JM; Flamant, F; Gruner, M; Hemet, J; Lefur, R; Lemerle, J; Tron, P; Vannier, JP1
Glinsmann-Gibson, BJ; Korc, M1
Huang, Y; Hui, DY1
Arkhipenko, VI; Spitsa, AI1
Raevskiĭ, IG1
Connelly, RR; Moldow, RE1

Reviews

1 review(s) available for dactinomycin and Pancreatic Neoplasms

ArticleYear
Pancreatic vipomas: spectrum of presentation and evolution of diagnostic and therapeutic modalities.
    Irish journal of medical science, 1995, Volume: 164, Issue:1

    Topics: Combined Modality Therapy; Dactinomycin; Diagnosis, Differential; Female; Humans; Male; Middle Aged; Pancreatectomy; Pancreatic Neoplasms; Prednisolone; Vasoactive Intestinal Peptide; Vipoma

1995

Trials

2 trial(s) available for dactinomycin and Pancreatic Neoplasms

ArticleYear
Randomized phase II clinical trial of adriamycin, methotrexate, and actinomycin-D in advanced measurable pancreatic carcinoma: a Gastrointestinal Tumor Study Group Report.
    Cancer, 1978, Volume: 42, Issue:1

    Topics: Adult; Aged; Bone Marrow; Clinical Trials as Topic; Dactinomycin; Doxorubicin; Drug Evaluation; Female; Humans; Male; Methotrexate; Middle Aged; Pancreatic Neoplasms; Remission, Spontaneous; Time Factors

1978
[A trial of clinical use of the antibiotic chrysomallin].
    Antibiotiki, 1967, Volume: 12, Issue:3

    Topics: Abdominal Muscles; Abdominal Neoplasms; Adult; Antineoplastic Agents; Choriocarcinoma; Clinical Trials as Topic; Dactinomycin; Female; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Pregnancy; Sarcoma; Stomach Neoplasms

1967

Other Studies

36 other study(ies) available for dactinomycin and Pancreatic Neoplasms

ArticleYear
Actinomycin-D and dimethylamino-parthenolide synergism in treating human pancreatic cancer cells.
    Drug development research, 2018, Volume: 79, Issue:6

    Topics: Aminopyrine; Antibiotics, Antineoplastic; Apoptosis; Dactinomycin; Drug Combinations; Drug Synergism; Growth Inhibitors; Humans; Pancreatic Neoplasms; Tumor Cells, Cultured

2018
Insulin-like growth factor 2 mRNA binding protein 2 promotes aerobic glycolysis and cell proliferation in pancreatic ductal adenocarcinoma via stabilizing GLUT1 mRNA.
    Acta biochimica et biophysica Sinica, 2019, Jul-10, Volume: 51, Issue:7

    Topics: Animals; Carcinoma, Pancreatic Ductal; Cell Line; Cell Line, Tumor; Cell Proliferation; Dactinomycin; Gene Expression Regulation, Neoplastic; Glucose Transporter Type 1; Glycolysis; HEK293 Cells; Humans; Kaplan-Meier Estimate; Male; Mice, Nude; Pancreatic Neoplasms; Protein Binding; RNA Interference; RNA-Binding Proteins; RNA, Messenger; RNAi Therapeutics; Xenograft Model Antitumor Assays

2019
Actinomycin D enhances killing of cancer cells by immunotoxin RG7787 through activation of the extrinsic pathway of apoptosis.
    Proceedings of the National Academy of Sciences of the United States of America, 2016, 09-20, Volume: 113, Issue:38

    Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Dactinomycin; Drug Resistance, Neoplasm; Drug Synergism; Humans; Immunoconjugates; Immunotoxins; Mesothelin; Mice; NF-kappa B; Pancreatic Neoplasms; Xenograft Model Antitumor Assays

2016
The phytostilbene resveratrol induces apoptosis in INS-1E rat insulinoma cells.
    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2009, Volume: 23, Issue:4-6

    Topics: Animals; Apoptosis; Caspases; Cell Cycle; Cell Line, Tumor; Dactinomycin; Insulin; Insulin-Secreting Cells; Insulinoma; Pancreatic Neoplasms; Phosphatidylserines; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; Resveratrol; Signal Transduction; Stilbenes; Time Factors

2009
Silencing of GRP94 expression promotes apoptosis in pancreatic cancer cells.
    International journal of oncology, 2009, Volume: 35, Issue:4

    Topics: Apoptosis; Biomarkers, Tumor; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Dactinomycin; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Membrane Glycoproteins; Neoplasm Staging; Nucleic Acid Synthesis Inhibitors; Pancreatic Neoplasms; Prognosis; Protein Synthesis Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; RNA, Messenger; RNA, Small Interfering; Time Factors; Transfection

2009
Actinomycin D synergistically enhances the efficacy of the BH3 mimetic ABT-737 by downregulating Mcl-1 expression.
    Cancer biology & therapy, 2010, Nov-01, Volume: 10, Issue:9

    Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; bcl-2 Homologous Antagonist-Killer Protein; bcl-2-Associated X Protein; Biphenyl Compounds; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Dactinomycin; Down-Regulation; Drug Synergism; Gene Expression; Humans; Myeloid Cell Leukemia Sequence 1 Protein; Nitrophenols; Pancreatic Neoplasms; Peptide Fragments; Piperazines; Polymerase Chain Reaction; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; RNA, Messenger; Sulfonamides

2010
Caspase-dependent and -independent panc-1 cell death due to actinomycin D and MK 886 are additive but increase clonogenic survival.
    Experimental biology and medicine (Maywood, N.J.), 2003, Volume: 228, Issue:8

    Topics: Caspases; Cell Death; Cell Division; Cell Survival; Dactinomycin; DNA Damage; DNA Fragmentation; Flow Cytometry; Humans; Indoles; Lipoxygenase Inhibitors; Nucleosomes; Pancreatic Neoplasms; Protein Synthesis Inhibitors; Tumor Cells, Cultured; Tumor Stem Cell Assay

2003
EARLY RESULTS OF COMBINED RADIATION AND CHEMOTHERAPY IN TREATMENT OF MALIGNANT TUMORS.
    Radiology, 1963, Volume: 81

    Topics: Antineoplastic Agents; Colonic Neoplasms; Dactinomycin; Fluorouracil; Humans; Lung Neoplasms; Mitomycin; Neoplasms; Pancreatic Neoplasms; Stomach Neoplasms

1963
EXPERIENCE WITH CHEMOTHERAPY OF CANCER AT THE UNIVERSITY OF PRETORIA.
    Acta - Unio Internationalis Contra Cancrum, 1964, Volume: 20

    Topics: Antineoplastic Agents; Aziridines; Breast Neoplasms; Cyclophosphamide; Dactinomycin; Fluorouracil; Hodgkin Disease; Humans; Intestinal Neoplasms; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Lymphoma; Lymphoma, Non-Hodgkin; Mannomustine; Mesothelioma; Multiple Myeloma; Neoplasms; Pancreatic Neoplasms; Sarcoma; South Africa; Stomach Neoplasms; Vinblastine

1964
[COMPARATIVE DATA ON THE EFFECT OF ACTINOMYCIN C AND K ON HUMAN TUMOR CELLS IN TISSUE CULTURE].
    Antibiotiki, 1964, Volume: 9

    Topics: Dactinomycin; Hemangiosarcoma; Kidney Neoplasms; Melanoma; Mesonephroma; Neoplasms; Neoplasms, Experimental; Pancreatic Neoplasms; Pharmacology; Research; Stomach Neoplasms; Tissue Culture Techniques

1964
[ANATOMICAL AND CLINICAL SERIAL OBSERVATIONS IN GIANT FOLLICULAR LYMPHOBLASTOMA (BRILL-SYMMERS DISEASE)].
    Blut, 1964, Volume: 10

    Topics: Antineoplastic Agents; Biliary Dyskinesia; Dactinomycin; Humans; Lymphoma; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Pancreatic Neoplasms

1964
The DNA damage-induced decrease of Bcl-2 is secondary to the activation of apoptotic effector caspases.
    Oncogene, 2003, Oct-09, Volume: 22, Issue:44

    Topics: Adenocarcinoma; Adenoviridae; Amino Acid Chloromethyl Ketones; Animals; Apoptosis; Apoptotic Protease-Activating Factor 1; Caspase Inhibitors; Caspases; Cell Transplantation; Dactinomycin; DNA Damage; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Enzyme Activation; Enzyme Inhibitors; Etoposide; Fibroblasts; Gene Deletion; Humans; Mice; Mice, SCID; Pancreatic Neoplasms; Proteins; Proto-Oncogene Proteins c-bcl-2; Transplantation, Heterologous; Tumor Cells, Cultured; Ultraviolet Rays

2003
Resveratrol inhibits pancreatic cancer cell proliferation through transcriptional induction of macrophage inhibitory cytokine-1.
    The Journal of surgical research, 2007, Volume: 138, Issue:2

    Topics: Antineoplastic Agents, Phytogenic; Bone Morphogenetic Proteins; Cell Division; Cell Line, Tumor; Dactinomycin; Gene Expression Regulation, Neoplastic; Growth Differentiation Factor 15; Humans; Nucleic Acid Synthesis Inhibitors; Oligonucleotide Array Sequence Analysis; Pancreatic Neoplasms; Resveratrol; RNA, Small Interfering; Stilbenes; Transcription, Genetic; Transfection; Up-Regulation

2007
Induction of interleukin-8 (CXCL-8) by tumor necrosis factor-alpha and leukemia inhibitory factor in pancreatic carcinoma cells: Impact of CXCL-8 as an autocrine growth factor.
    International journal of oncology, 2007, Volume: 31, Issue:3

    Topics: Cell Line, Tumor; Cell Proliferation; Cycloheximide; Cytokines; Dactinomycin; Humans; Immunoglobulin G; Inflammation; Intercellular Signaling Peptides and Proteins; Interleukin-8; Leukemia Inhibitory Factor; Pancreatic Neoplasms; RNA, Messenger; Time Factors; Tumor Necrosis Factor-alpha

2007
Neuropilin-1 interacts with integrin beta1 and modulates pancreatic cancer cell growth, survival and invasion.
    Cancer biology & therapy, 2007, Volume: 6, Issue:8

    Topics: Antibiotics, Antineoplastic; Apoptosis Regulatory Proteins; bcl-X Protein; Caspase 9; Cell Adhesion; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dactinomycin; DNA, Antisense; Humans; Integrin beta1; Neoplasm Invasiveness; Neuropilin-1; Pancreatic Neoplasms; Poly(ADP-ribose) Polymerases; STAT5 Transcription Factor

2007
Metastatic pancreatic vipoma: a case report of clinical response following treatment with corticosteroids and actinomycin D.
    Clinical oncology, 1982, Volume: 8, Issue:2

    Topics: Adenoma, Islet Cell; Dactinomycin; Female; Humans; Indomethacin; Liver Neoplasms; Middle Aged; Pancreatic Neoplasms; Prednisolone; Vasoactive Intestinal Peptide; Vipoma

1982
Apoptotic cell death triggered by nitric oxide in pancreatic beta-cells.
    Diabetes, 1995, Volume: 44, Issue:7

    Topics: Amino Acid Oxidoreductases; Animals; Apoptosis; Cell Survival; Cricetinae; Cycloheximide; Dactinomycin; DNA; Electrophoresis, Agar Gel; Gene Expression; Humans; Insulinoma; Interleukin-1; Islets of Langerhans; Kinetics; Microscopy, Electron, Scanning; Nitric Oxide; Nitric Oxide Synthase; Nitroprusside; Nucleosomes; Pancreatic Neoplasms; Penicillamine; Rats; Rats, Sprague-Dawley; Recombinant Proteins; RNA, Messenger; S-Nitroso-N-Acetylpenicillamine; Time Factors; Tumor Cells, Cultured

1995
Glucagon-like peptide-1 affects gene transcription and messenger ribonucleic acid stability of components of the insulin secretory system in RIN 1046-38 cells.
    Endocrinology, 1995, Volume: 136, Issue:11

    Topics: Animals; Culture Media, Conditioned; Cycloheximide; Dactinomycin; Drug Stability; Drug Synergism; Gene Expression Regulation; Glucagon; Glucagon-Like Peptide 1; Glucose; Glucose Transporter Type 1; Hexokinase; Insulin; Insulin Secretion; Insulinoma; Monosaccharide Transport Proteins; Pancreatic Neoplasms; Peptide Fragments; Protein Precursors; Rats; RNA, Messenger; Transcription, Genetic; Tumor Cells, Cultured

1995
Protein kinase C mediates down-regulation of cystic fibrosis transmembrane conductance regulator levels in epithelial cells.
    The Journal of biological chemistry, 1993, Jul-05, Volume: 268, Issue:19

    Topics: Adenocarcinoma; Colonic Neoplasms; Cycloheximide; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Dactinomycin; Epithelium; Gene Expression Regulation, Neoplastic; Humans; Indoles; Maleimides; Membrane Proteins; Pancreatic Neoplasms; Protein Biosynthesis; Protein Kinase C; RNA, Neoplasm; Tetradecanoylphorbol Acetate; Transcription, Genetic; Transfection; Tumor Cells, Cultured

1993
Tissue-type plasminogen activator predicts endocrine responsiveness of human pancreatic carcinoma cells.
    Cancer, 1995, Mar-15, Volume: 75, Issue:6

    Topics: Animals; Aromatase Inhibitors; Binding Sites; Cycloheximide; Dactinomycin; Drug Screening Assays, Antitumor; Estrogens; Female; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Neoplasms, Hormone-Dependent; Pancreatic Neoplasms; Receptors, Estrogen; Tissue Plasminogen Activator; Toremifene; Tumor Cells, Cultured

1995
The use of 7-amino actinomycin D in identifying apoptosis: simplicity of use and broad spectrum of application compared with other techniques.
    Blood, 1996, Mar-15, Volume: 87, Issue:6

    Topics: Apoptosis; Camptothecin; Carcinoma; Cell Count; Cell Separation; Dactinomycin; DNA Damage; DNA, Neoplasm; Flow Cytometry; Fluorescent Dyes; Humans; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Erythroblastic, Acute; Pancreatic Neoplasms; Reproducibility of Results; Sensitivity and Specificity; Tumor Cells, Cultured

1996
"Response to Hord and Janco re chemotherapy for unresectable pancreatoblastoma".
    Medical and pediatric oncology, 1997, Volume: 29, Issue:3

    Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Dactinomycin; Drug Resistance, Neoplasm; Fatal Outcome; Follow-Up Studies; Humans; Ifosfamide; Male; Pancreatic Neoplasms; Vincristine

1997
Differential regulation of somatostatin receptor type 2 (sst 2) expression in AR4-2J tumor cells implanted into mice during octreotide treatment.
    Cancer research, 1999, Aug-01, Volume: 59, Issue:15

    Topics: Animals; Antineoplastic Agents, Hormonal; Cycloheximide; Dactinomycin; Gene Expression Regulation, Neoplastic; Mice; Mice, SCID; Neoplasm Proteins; Nucleic Acid Synthesis Inhibitors; Octreotide; Pancreatic Neoplasms; Protein Synthesis Inhibitors; Rats; Receptors, Somatostatin; Somatostatin; Tumor Cells, Cultured; Up-Regulation

1999
Forskolin and phorbol ester have opposite effects on the expression of mucin-associated sialyl-Lewis(a) in pancreatic cancer cells.
    European journal of cancer (Oxford, England : 1990), 2000, Volume: 36, Issue:1

    Topics: Blotting, Western; Colforsin; Cyclic AMP-Dependent Protein Kinases; Dactinomycin; Humans; Mucin-1; Oligosaccharides; Pancreatic Neoplasms; Phorbol Esters; Protein Kinase C; RNA, Messenger; Sialyl Lewis X Antigen; Tumor Cells, Cultured

2000
Actinomycin D induces apoptosis and inhibits growth of pancreatic cancer cells.
    International journal of cancer, 2000, May-01, Volume: 86, Issue:3

    Topics: Antibiotics, Antineoplastic; Apoptosis; bcl-2-Associated X Protein; bcl-Associated Death Protein; Carrier Proteins; Cell Division; Dactinomycin; Humans; Pancreatic Neoplasms; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Tumor Cells, Cultured; Tumor Suppressor Protein p53

2000
Combination of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and actinomycin D induces apoptosis even in TRAIL-resistant human pancreatic cancer cells.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2001, Volume: 7, Issue:2

    Topics: Antibiotics, Antineoplastic; Apoptosis; Apoptosis Regulatory Proteins; Blotting, Western; Cell Division; Dactinomycin; DNA Primers; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Therapy, Combination; Humans; Immunoenzyme Techniques; In Situ Nick-End Labeling; Ligands; Membrane Glycoproteins; Pancreatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; TNF-Related Apoptosis-Inducing Ligand; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Tumor Suppressor Protein p53

2001
CD95-related apoptotic machinery is functional in pancreatic cancer cells.
    Pancreas, 2001, Volume: 22, Issue:4

    Topics: Adenocarcinoma; Apoptosis; Bleomycin; Dactinomycin; Enzyme Activation; fas Receptor; Flow Cytometry; Genes, p53; Humans; Interferon-gamma; Kinetics; Mutation; Paclitaxel; Pancreatic Neoplasms; Peptide Hydrolases; Signal Transduction; Tumor Cells, Cultured

2001
Molecular mechanism(s) of actinomycin-D induced sensitization of pancreatic cancer cells to CD95 mediated apoptosis.
    International journal of oncology, 2002, Volume: 20, Issue:1

    Topics: Adenocarcinoma; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Apoptosis; Blotting, Western; Cell Survival; Dactinomycin; Drug Resistance; Electrophoretic Mobility Shift Assay; Enzyme Activation; Enzyme Inhibitors; fas Receptor; Flow Cytometry; Humans; NF-kappa B; Pancreatic Neoplasms; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Protein Binding; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Signal Transduction; Tumor Cells, Cultured

2002
Purification and characterization of a plasminogen activator secreted by cultured human pancreatic carcinoma cells.
    Biochemistry, 1977, May-03, Volume: 16, Issue:9

    Topics: Carcinoma; Cells, Cultured; Cycloheximide; Dactinomycin; Hot Temperature; Humans; Hydrogen-Ion Concentration; Isoelectric Point; Molecular Weight; Pancreatic Neoplasms; Plasminogen Activators

1977
Islet cell carcinoma of the pancreas.
    Archives of pathology, 1975, Volume: 99, Issue:4

    Topics: Adenoma, Islet Cell; Adolescent; Adult; Aged; Child; Cyclophosphamide; Dactinomycin; Female; Fluorouracil; Humans; Hyperglycemia; Hypoglycemia; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Pancreas; Pancreatic Neoplasms; Streptozocin

1975
Inhibitory effect of islet amyloid polypeptide of glucose-induced proinsulin biosynthesis in rat insulinoma cells.
    Pancreas, 1992, Volume: 7, Issue:4

    Topics: Amyloid; Animals; Dactinomycin; Dose-Response Relationship, Drug; Glucose; Insulinoma; Islet Amyloid Polypeptide; Islets of Langerhans; Pancreatic Neoplasms; Proinsulin; Rats; Tumor Cells, Cultured

1992
Pancreatoblastoma: response to chemotherapy.
    Medical and pediatric oncology, 1991, Volume: 19, Issue:3

    Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Epirubicin; Etoposide; Female; Humans; Ifosfamide; Lymphatic Metastasis; Male; Pancreatic Neoplasms; Vinblastine; Vincristine

1991
Regulation of transforming growth factor-alpha mRNA expression in T3M4 human pancreatic carcinoma cells.
    Pancreas, 1991, Volume: 6, Issue:2

    Topics: Dactinomycin; Epidermal Growth Factor; Gene Expression Regulation, Neoplastic; Humans; Nucleic Acid Hybridization; Pancreatic Neoplasms; RNA, Messenger; RNA, Neoplasm; Tetradecanoylphorbol Acetate; Transforming Growth Factor alpha; Tumor Cells, Cultured

1991
Cholesterol esterase biosynthesis in rat pancreatic AR42J cells. Post-transcriptional activation by gastric hormones.
    The Journal of biological chemistry, 1991, Apr-15, Volume: 266, Issue:11

    Topics: Animals; Cell Line; Cholecystokinin; Dactinomycin; Enzyme Activation; Enzyme Induction; Kinetics; Molecular Weight; Pancreatic Neoplasms; Protein Biosynthesis; Rats; RNA, Neoplasm; Secretin; Sterol Esterase

1991
[The effect of hormones and actinomycin on tumor cell multiplication in in vitro experiments].
    Voprosy onkologii, 1971, Volume: 17, Issue:4

    Topics: Antibiotics, Antineoplastic; Carcinoma; Dactinomycin; Female; Flavonoids; In Vitro Techniques; Insulin; Neoplasm Transplantation; Ovarian Neoplasms; Pancreatic Neoplasms; Thyroxine

1971
Epidemiology of pancreatic cancer in Connecticut.
    Gastroenterology, 1968, Volume: 55, Issue:6

    Topics: Adenocarcinoma; Adult; Age Factors; Aged; Black People; Carcinoma; Carcinoma, Intraductal, Noninfiltrating; Connecticut; Cystadenocarcinoma; Dactinomycin; Family Characteristics; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Nitrogen Mustard Compounds; Pancreatic Neoplasms; Prognosis; Religion; Residence Characteristics; Seasons; Sex Factors; Thiotepa; White People

1968